Lv51
930 积分 2024-07-12 加入
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models
5小时前
待确认
Sequential CD19-20 CAR T-cell therapy for refractory/relapsed diffuse large B-cell lymphoma
3天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
3天前
已完结
CAR-T therapy in solid tumors
3天前
已完结
The clinical pipeline for cancer cell therapies
3天前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
12天前
已完结
Albumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation
1个月前
已完结
A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo
1个月前
已完结
A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice
1个月前
已完结
Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
1个月前
已完结
皖公网安备34019202002308
